Central Nervous System (CNS) neoplasms
Showing 1 - 25 of >10,000
Germ Cell Tumors of the Central Nervous System
Recruiting
- Germ Cell Tumor of CNS
-
Beijing, ChinaSanbo Brain Hospital Capital Medical University
Apr 19, 2023
Brain Slice Explants to Predict Drug Response in Brain Tumors
Not yet recruiting
- Central Nervous System Tumor
- Biospecimen collection
-
Chapel Hill, North CarolinaUNC Lineberger Comprehensive Cancer Center
Jul 28, 2023
Diffuse Intrinsic Pontine Glioma, Diffuse Midline Glioma, Recurrent CNS Tumor, Adult Trial in Seattle (SC-CAR4BRAIN)
Not yet recruiting
- Diffuse Intrinsic Pontine Glioma
- +4 more
- SC-CAR4BRAIN
-
Seattle, WashingtonSeattle Children's Hospital
Mar 3, 2023
CNS Tumors, Atypical Teratoid/Rhabdoid Tumor, Diffuse Midline Glioma, H3 K27M-Mutant Trial in Memphis (B7-H3-CAR T cells)
Not yet recruiting
- Central Nervous System Neoplasms
- +6 more
- B7-H3-CAR T cells
-
Memphis, TennesseeSt. Jude Children's Research Hospital
Apr 18, 2023
CNS Qualitative Interview
Recruiting
- Central Nervous System Cancer
- Qualitative Interviews
-
Aurora, ColoradoChildren's Hospital Colorado
Oct 31, 2022
Nervous System Tumor Trial (Administration of Indocyanine Green (ICG) and Visualization of Tumor)
Not yet recruiting
- Nervous System Tumor
- Administration of Indocyanine Green (ICG) and Visualization of Tumor
- (no location specified)
Feb 17, 2023
CNS Germinoma, CNS Tumor, Asian Consortium Trial in Goyang-si (Radiation Therapy)
Recruiting
- CNS Germinoma
- +2 more
- Radiation Therapy
-
Goyang-si, Gyeonggi-do, Korea, Republic ofNational Cancer Center, Korea
Aug 7, 2023
CNS Tumor, Pediatric, Glioma, Ependymoma Trial in Seattle (EGFR806-specific chimeric antigen receptor (CAR) T cell)
Active, not recruiting
- Central Nervous System Tumor, Pediatric
- +8 more
- EGFR806-specific chimeric antigen receptor (CAR) T cell
-
Seattle, WashingtonSeattle Children's Hospital
Jan 18, 2023
Artificial Intelligence in CNS Radiation Oncology
Not yet recruiting
- CNS Tumor
- The images (CT, MRI, PET) used for RT planning, mid-treatment imaging as part of IGRT or disease evaluation, and response assessment/ surveillance post-RT
- (no location specified)
Sep 6, 2023
CNS Tumor, Pediatric, Glioma, Ependymoma Trial in Seattle (HER2-specific chimeric antigen receptor (CAR) T cell)
Recruiting
- Central Nervous System Tumor, Pediatric
- +8 more
- HER2-specific chimeric antigen receptor (CAR) T cell
-
Seattle, WashingtonSeattle Children's Hospital
Dec 14, 2022
A Study of Metabolic Agents Following Brain Radiation
Enrolling by invitation
- CNS Malignancy
- F-DOPA Positron Emission Tomography
- Chemical Exchange Saturation Transfer Magnetic Resonance Imaging
-
Rochester, MinnesotaMayo Clinic
Nov 21, 2023
Breast Cancer Trial in New York (MRI, Lumbar puncture)
Recruiting
- Breast Cancer
- MRI
- Lumbar puncture
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Jul 14, 2022
68-Ga DOTATATE PET/MRI in Diagnosis and Management of
Recruiting
- CNS Tumors
- +6 more
- Ga68-DOTATATE-PET/MRI
-
New York, New YorkWeill Cornell Medicine
Sep 20, 2022
Diffuse Midline Glioma (DMG), Glioblastoma, Recurrent Ependymoma Trial in San Francisco, Ann Arbor, Zürich (ONC206, Standard of
Recruiting
- Diffuse Midline Glioma (DMG)
- +7 more
- ONC206
- Standard of Care Radiation Therapy
-
San Francisco, California
- +2 more
Sep 13, 2022
Clinical Stage IV Cutaneous Melanoma AJCC v8, Metastatic Malignant Tumor in the Brain, Metastatic Malignant Tumor in the CNS
Recruiting
- Clinical Stage IV Cutaneous Melanoma AJCC v8
- +3 more
- Dabrafenib
- MEK-1/MEKK-1 Inhibitor E6201
-
Scottsdale, Arizona
- +2 more
Jan 4, 2023
Malignant Melanoma, Brain Metastases Trial in Tucson (E6201, E6201 plus dabrafenib)
Terminated
- Malignant Melanoma
- Brain Metastases
- E6201
- E6201 plus dabrafenib
-
Tucson, ArizonaUniversity of Arizona Cancer Center
Mar 5, 2022
CNS Tumors, CNS Tumor Trial in Saint Louis (Tc-99m tilmanocept)
Recruiting
- Central Nervous System Neoplasms
- Central Nervous System Tumor
- Tc-99m tilmanocept
-
Saint Louis, MissouriWashington University School of Medicine
Jan 28, 2022
Metastatic Cancer, CNS Cancer Trial in Boston (Niraparib)
Recruiting
- Metastatic Cancer
- Central Nervous System Cancer
-
Boston, Massachusetts
- +2 more
Jan 28, 2022
CNS Tumor, Cranial Nerve Disorder, Metastatic Malignant Tumor in the Brain Trial in Portland (Ferumoxytol, Gadolinium, Magnetic
Recruiting
- Central Nervous System Neoplasm
- +2 more
- Ferumoxytol
- +2 more
-
Portland, OregonOHSU Knight Cancer Institute
Jun 2, 2022
CNS Tumors Trial in Worldwide (Avelumab, Lenvatinib)
Recruiting
- Central Nervous System Tumors
-
Saint Louis, Missouri
- +9 more
Jul 21, 2022
Pediatric CNS Tumor Trial in United States (tozuleristide, Canvas System)
Completed
- Pediatric Central Nervous System Tumor
- tozuleristide
- Canvas System
-
Los Angeles, California
- +8 more
Nov 9, 2022
Cognitive Function After Treatment of Primary CNS Malignancy
Recruiting
- CNS Malignancy
-
Rochester, MinnesotaMayo Clinic in Rochester
Jun 22, 2022
Patients With Brain Tumors Undergoing Surgery
Recruiting
- Central Nervous System Neoplasm
- +3 more
- Biospecimen Collection
- Laboratory Biomarker Analysis
-
Rochester, MinnesotaMayo Clinic in Rochester
Sep 29, 2022
High Grade Glioma, Meningioma, Embryonal Tumor Trial in United States (LUTATHERA® (Lutetium Lu 177 dotatate))
Recruiting
- High Grade Glioma
- +12 more
- LUTATHERA® (Lutetium Lu 177 dotatate)
-
Aurora, Colorado
- +8 more
Jan 16, 2023